Table of Content

1 Report Overview
1.1 T Cell Surface Glycoprotein CD4 Definition
1.2 Market by Type
1.2.1 Global T Cell Surface Glycoprotein CD4 Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Forigerimod Acetate
1.2.3 HIV Vaccine 2
1.2.4 Ibalizumab
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global T Cell Surface Glycoprotein CD4 Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 HIV
1.3.3 AIDS
1.3.4 GVHD
1.3.5 SARS
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global T Cell Surface Glycoprotein CD4 Sales
2.1 Global T Cell Surface Glycoprotein CD4 Revenue Estimates and Forecasts 2018-2034
2.2 Global T Cell Surface Glycoprotein CD4 Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global T Cell Surface Glycoprotein CD4 Revenue by Region
2.3.1 Global T Cell Surface Glycoprotein CD4 Revenue by Region (2018-2023)
2.3.2 Global T Cell Surface Glycoprotein CD4 Revenue by Region (2024-2034)
2.4 Global T Cell Surface Glycoprotein CD4 Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global T Cell Surface Glycoprotein CD4 Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global T Cell Surface Glycoprotein CD4 Sales Quantity by Region
2.6.1 Global T Cell Surface Glycoprotein CD4 Sales Quantity by Region (2018-2023)
2.6.2 Global T Cell Surface Glycoprotein CD4 Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global T Cell Surface Glycoprotein CD4 Sales Quantity by Manufacturers
3.1.1 Global T Cell Surface Glycoprotein CD4 Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global T Cell Surface Glycoprotein CD4 Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by T Cell Surface Glycoprotein CD4 Sales in 2024
3.2 Global T Cell Surface Glycoprotein CD4 Revenue by Manufacturers
3.2.1 Global T Cell Surface Glycoprotein CD4 Revenue by Manufacturers (2018-2023)
3.2.2 Global T Cell Surface Glycoprotein CD4 Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by T Cell Surface Glycoprotein CD4 Revenue in 2024
3.3 Global T Cell Surface Glycoprotein CD4 Sales Price by Manufacturers
3.4 Global Key Players of T Cell Surface Glycoprotein CD4, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global T Cell Surface Glycoprotein CD4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of T Cell Surface Glycoprotein CD4, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of T Cell Surface Glycoprotein CD4, Product Offered and Application
3.8 Global Key Manufacturers of T Cell Surface Glycoprotein CD4, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global T Cell Surface Glycoprotein CD4 Sales Quantity by Type
4.1.1 Global T Cell Surface Glycoprotein CD4 Historical Sales Quantity by Type (2018-2023)
4.1.2 Global T Cell Surface Glycoprotein CD4 Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Type (2018-2034)
4.2 Global T Cell Surface Glycoprotein CD4 Revenue by Type
4.2.1 Global T Cell Surface Glycoprotein CD4 Historical Revenue by Type (2018-2023)
4.2.2 Global T Cell Surface Glycoprotein CD4 Forecasted Revenue by Type (2024-2034)
4.2.3 Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2018-2034)
4.3 Global T Cell Surface Glycoprotein CD4 Price by Type
4.3.1 Global T Cell Surface Glycoprotein CD4 Price by Type (2018-2023)
4.3.2 Global T Cell Surface Glycoprotein CD4 Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global T Cell Surface Glycoprotein CD4 Sales Quantity by Application
5.1.1 Global T Cell Surface Glycoprotein CD4 Historical Sales Quantity by Application (2018-2023)
5.1.2 Global T Cell Surface Glycoprotein CD4 Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Application (2018-2034)
5.2 Global T Cell Surface Glycoprotein CD4 Revenue by Application
5.2.1 Global T Cell Surface Glycoprotein CD4 Historical Revenue by Application (2018-2023)
5.2.2 Global T Cell Surface Glycoprotein CD4 Forecasted Revenue by Application (2024-2034)
5.2.3 Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2018-2034)
5.3 Global T Cell Surface Glycoprotein CD4 Price by Application
5.3.1 Global T Cell Surface Glycoprotein CD4 Price by Application (2018-2023)
5.3.2 Global T Cell Surface Glycoprotein CD4 Price Forecast by Application (2024-2034)
6 North America
6.1 North America T Cell Surface Glycoprotein CD4 Sales by Company
6.1.1 North America T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2023)
6.1.2 North America T Cell Surface Glycoprotein CD4 Sales Quantity by Company (2018-2023)
6.2 North America T Cell Surface Glycoprotein CD4 Market Size by Type
6.2.1 North America T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2034)
6.2.2 North America T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2034)
6.3 North America T Cell Surface Glycoprotein CD4 Market Size by Application
6.3.1 North America T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2034)
6.3.2 North America T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2034)
6.4 North America T Cell Surface Glycoprotein CD4 Market Size by Country
6.4.1 North America T Cell Surface Glycoprotein CD4 Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America T Cell Surface Glycoprotein CD4 Revenue by Country (2018-2034)
6.4.3 North America T Cell Surface Glycoprotein CD4 Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe T Cell Surface Glycoprotein CD4 Sales by Company
7.1.1 Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Company (2018-2023)
7.1.2 Europe T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2023)
7.2 Europe T Cell Surface Glycoprotein CD4 Market Size by Type
7.2.1 Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2034)
7.2.2 Europe T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2034)
7.3 Europe T Cell Surface Glycoprotein CD4 Market Size by Application
7.3.1 Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2034)
7.3.2 Europe T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2034)
7.4 Europe T Cell Surface Glycoprotein CD4 Market Size by Country
7.4.1 Europe T Cell Surface Glycoprotein CD4 Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2018-2034)
7.4.3 Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China T Cell Surface Glycoprotein CD4 Sales by Company
8.1.1 China T Cell Surface Glycoprotein CD4 Sales Quantity by Company (2018-2023)
8.1.2 China T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2023)
8.2 China T Cell Surface Glycoprotein CD4 Market Size by Type
8.2.1 China T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2034)
8.2.2 China T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2034)
8.3 China T Cell Surface Glycoprotein CD4 Market Size by Application
8.3.1 China T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2034)
8.3.2 China T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC T Cell Surface Glycoprotein CD4 Sales by Company
9.1.1 APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Company (2018-2023)
9.1.2 APAC T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2023)
9.2 APAC T Cell Surface Glycoprotein CD4 Market Size by Type
9.2.1 APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2034)
9.2.2 APAC T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2034)
9.3 APAC T Cell Surface Glycoprotein CD4 Market Size by Application
9.3.1 APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2034)
9.3.2 APAC T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2034)
9.4 APAC T Cell Surface Glycoprotein CD4 Market Size by Region
9.4.1 APAC T Cell Surface Glycoprotein CD4 Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC T Cell Surface Glycoprotein CD4 Revenue by Region (2018-2034)
9.4.3 APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales by Company
10.1.1 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Market Size by Type
10.2.1 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Market Size by Application
10.3.1 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Market Size by Country
10.4.1 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Biotest AG
11.1.1 Biotest AG Company Information
11.1.2 Biotest AG Overview
11.1.3 Biotest AG T Cell Surface Glycoprotein CD4 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Biotest AG T Cell Surface Glycoprotein CD4 Products and Services
11.1.5 Biotest AG T Cell Surface Glycoprotein CD4 SWOT Analysis
11.1.6 Biotest AG Recent Developments
11.2 Bristol-Myers Squibb Co
11.2.1 Bristol-Myers Squibb Co Company Information
11.2.2 Bristol-Myers Squibb Co Overview
11.2.3 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Products and Services
11.2.5 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 SWOT Analysis
11.2.6 Bristol-Myers Squibb Co Recent Developments
11.3 CEL-SCI Corp
11.3.1 CEL-SCI Corp Company Information
11.3.2 CEL-SCI Corp Overview
11.3.3 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Products and Services
11.3.5 CEL-SCI Corp T Cell Surface Glycoprotein CD4 SWOT Analysis
11.3.6 CEL-SCI Corp Recent Developments
11.4 Fountain Biopharma Inc
11.4.1 Fountain Biopharma Inc Company Information
11.4.2 Fountain Biopharma Inc Overview
11.4.3 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Products and Services
11.4.5 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 SWOT Analysis
11.4.6 Fountain Biopharma Inc Recent Developments
11.5 Immupharma Plc
11.5.1 Immupharma Plc Company Information
11.5.2 Immupharma Plc Overview
11.5.3 Immupharma Plc T Cell Surface Glycoprotein CD4 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Immupharma Plc T Cell Surface Glycoprotein CD4 Products and Services
11.5.5 Immupharma Plc T Cell Surface Glycoprotein CD4 SWOT Analysis
11.5.6 Immupharma Plc Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Overview
11.6.3 Sanofi T Cell Surface Glycoprotein CD4 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Sanofi T Cell Surface Glycoprotein CD4 Products and Services
11.6.5 Sanofi T Cell Surface Glycoprotein CD4 SWOT Analysis
11.6.6 Sanofi Recent Developments
11.7 TaiMed Biologics Inc
11.7.1 TaiMed Biologics Inc Company Information
11.7.2 TaiMed Biologics Inc Overview
11.7.3 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Products and Services
11.7.5 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 SWOT Analysis
11.7.6 TaiMed Biologics Inc Recent Developments
11.8 United Biomedical Inc
11.8.1 United Biomedical Inc Company Information
11.8.2 United Biomedical Inc Overview
11.8.3 United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 United Biomedical Inc T Cell Surface Glycoprotein CD4 Products and Services
11.8.5 United Biomedical Inc T Cell Surface Glycoprotein CD4 SWOT Analysis
11.8.6 United Biomedical Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 T Cell Surface Glycoprotein CD4 Value Chain Analysis
12.2 T Cell Surface Glycoprotein CD4 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 T Cell Surface Glycoprotein CD4 Production Mode & Process
12.4 T Cell Surface Glycoprotein CD4 Sales and Marketing
12.4.1 T Cell Surface Glycoprotein CD4 Sales Channels
12.4.2 T Cell Surface Glycoprotein CD4 Distributors
12.5 T Cell Surface Glycoprotein CD4 Customers
13 Market Dynamics
13.1 T Cell Surface Glycoprotein CD4 Industry Trends
13.2 T Cell Surface Glycoprotein CD4 Market Drivers
13.3 T Cell Surface Glycoprotein CD4 Market Challenges
13.4 T Cell Surface Glycoprotein CD4 Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global T Cell Surface Glycoprotein CD4 Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Forigerimod Acetate
Table 3. Major Manufacturers of HIV Vaccine 2
Table 4. Major Manufacturers of Ibalizumab
Table 5. Major Manufacturers of Others
Table 6. Global T Cell Surface Glycoprotein CD4 Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global T Cell Surface Glycoprotein CD4 Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global T Cell Surface Glycoprotein CD4 Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2018-2023)
Table 10. Global T Cell Surface Glycoprotein CD4 Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2024-2034)
Table 12. Global T Cell Surface Glycoprotein CD4 Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 13. Global T Cell Surface Glycoprotein CD4 Sales by Region (2018-2023) & (K Pcs)
Table 14. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2018-2023)
Table 15. Global T Cell Surface Glycoprotein CD4 Sales by Region (2024-2034) & (K Pcs)
Table 16. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2024-2034)
Table 17. Global T Cell Surface Glycoprotein CD4 Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 18. Global T Cell Surface Glycoprotein CD4 Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global T Cell Surface Glycoprotein CD4 Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global T Cell Surface Glycoprotein CD4 Revenue Share by Manufacturers (2018-2023)
Table 21. Global T Cell Surface Glycoprotein CD4 Price by Manufacturers 2018-2023 (USD/Pcs)
Table 22. Global Key Players of T Cell Surface Glycoprotein CD4, Industry Ranking, 2021 VS 2024
Table 23. Global T Cell Surface Glycoprotein CD4 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global T Cell Surface Glycoprotein CD4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Cell Surface Glycoprotein CD4 as of 2024)
Table 25. Global Key Manufacturers of T Cell Surface Glycoprotein CD4, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of T Cell Surface Glycoprotein CD4, Product Offered and Application
Table 27. Global Key Manufacturers of T Cell Surface Glycoprotein CD4, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 30. Global T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 31. Global T Cell Surface Glycoprotein CD4 Sales Quantity Share by Type (2018-2023)
Table 32. Global T Cell Surface Glycoprotein CD4 Sales Quantity Share by Type (2024-2034)
Table 33. Global T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global T Cell Surface Glycoprotein CD4 Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global T Cell Surface Glycoprotein CD4 Revenue Share by Type (2018-2023)
Table 36. Global T Cell Surface Glycoprotein CD4 Revenue Share by Type (2024-2034)
Table 37. T Cell Surface Glycoprotein CD4 Price by Type (2018-2023) & (USD/Pcs)
Table 38. Global T Cell Surface Glycoprotein CD4 Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 39. Global T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 40. Global T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 41. Global T Cell Surface Glycoprotein CD4 Sales Quantity Share by Application (2018-2023)
Table 42. Global T Cell Surface Glycoprotein CD4 Sales Quantity Share by Application (2024-2034)
Table 43. Global T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global T Cell Surface Glycoprotein CD4 Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global T Cell Surface Glycoprotein CD4 Revenue Share by Application (2018-2023)
Table 46. Global T Cell Surface Glycoprotein CD4 Revenue Share by Application (2024-2034)
Table 47. T Cell Surface Glycoprotein CD4 Price by Application (2018-2023) & (USD/Pcs)
Table 48. Global T Cell Surface Glycoprotein CD4 Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 49. North America T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America T Cell Surface Glycoprotein CD4 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 51. North America T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 52. North America T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 53. North America T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America T Cell Surface Glycoprotein CD4 Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 56. North America T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 57. North America T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America T Cell Surface Glycoprotein CD4 Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America T Cell Surface Glycoprotein CD4 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America T Cell Surface Glycoprotein CD4 Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America T Cell Surface Glycoprotein CD4 Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America T Cell Surface Glycoprotein CD4 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 63. North America T Cell Surface Glycoprotein CD4 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 64. Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 65. Europe T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 67. Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 68. Europe T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe T Cell Surface Glycoprotein CD4 Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 71. Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 72. Europe T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe T Cell Surface Glycoprotein CD4 Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe T Cell Surface Glycoprotein CD4 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 78. Europe T Cell Surface Glycoprotein CD4 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 79. China T Cell Surface Glycoprotein CD4 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 80. China T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2023) & (US$ Million)
Table 81. China T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 82. China T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 83. China T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2023) & (US$ Million)
Table 84. China T Cell Surface Glycoprotein CD4 Revenue by Type (2024-2034) & (US$ Million)
Table 85. China T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 86. China T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 87. China T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2023) & (US$ Million)
Table 88. China T Cell Surface Glycoprotein CD4 Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 90. APAC T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 92. APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 93. APAC T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC T Cell Surface Glycoprotein CD4 Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 96. APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 97. APAC T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC T Cell Surface Glycoprotein CD4 Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC T Cell Surface Glycoprotein CD4 Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC T Cell Surface Glycoprotein CD4 Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC T Cell Surface Glycoprotein CD4 Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Region (2018-2023) & (K Pcs)
Table 103. APAC T Cell Surface Glycoprotein CD4 Sales Quantity by Region (2024-2034) & (K Pcs)
Table 104. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 105. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 108. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 111. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 112. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 118. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 119. Biotest AG Company Information
Table 120. Biotest AG Description and Overview
Table 121. Biotest AG T Cell Surface Glycoprotein CD4 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Biotest AG T Cell Surface Glycoprotein CD4 Product and Services
Table 123. Biotest AG T Cell Surface Glycoprotein CD4 SWOT Analysis
Table 124. Biotest AG Recent Developments
Table 125. Bristol-Myers Squibb Co Company Information
Table 126. Bristol-Myers Squibb Co Description and Overview
Table 127. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 128. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product and Services
Table 129. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 SWOT Analysis
Table 130. Bristol-Myers Squibb Co Recent Developments
Table 131. CEL-SCI Corp Company Information
Table 132. CEL-SCI Corp Description and Overview
Table 133. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 134. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product and Services
Table 135. CEL-SCI Corp T Cell Surface Glycoprotein CD4 SWOT Analysis
Table 136. CEL-SCI Corp Recent Developments
Table 137. Fountain Biopharma Inc Company Information
Table 138. Fountain Biopharma Inc Description and Overview
Table 139. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 140. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product and Services
Table 141. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 SWOT Analysis
Table 142. Fountain Biopharma Inc Recent Developments
Table 143. Immupharma Plc Company Information
Table 144. Immupharma Plc Description and Overview
Table 145. Immupharma Plc T Cell Surface Glycoprotein CD4 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 146. Immupharma Plc T Cell Surface Glycoprotein CD4 Product and Services
Table 147. Immupharma Plc T Cell Surface Glycoprotein CD4 SWOT Analysis
Table 148. Immupharma Plc Recent Developments
Table 149. Sanofi Company Information
Table 150. Sanofi Description and Overview
Table 151. Sanofi T Cell Surface Glycoprotein CD4 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 152. Sanofi T Cell Surface Glycoprotein CD4 Product and Services
Table 153. Sanofi T Cell Surface Glycoprotein CD4 SWOT Analysis
Table 154. Sanofi Recent Developments
Table 155. TaiMed Biologics Inc Company Information
Table 156. TaiMed Biologics Inc Description and Overview
Table 157. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 158. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product and Services
Table 159. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 SWOT Analysis
Table 160. TaiMed Biologics Inc Recent Developments
Table 161. United Biomedical Inc Company Information
Table 162. United Biomedical Inc Description and Overview
Table 163. United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 164. United Biomedical Inc T Cell Surface Glycoprotein CD4 Product and Services
Table 165. United Biomedical Inc T Cell Surface Glycoprotein CD4 SWOT Analysis
Table 166. United Biomedical Inc Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. T Cell Surface Glycoprotein CD4 Distributors List
Table 170. T Cell Surface Glycoprotein CD4 Customers List
Table 171. T Cell Surface Glycoprotein CD4 Market Trends
Table 172. T Cell Surface Glycoprotein CD4 Market Drivers
Table 173. T Cell Surface Glycoprotein CD4 Market Challenges
Table 174. T Cell Surface Glycoprotein CD4 Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. T Cell Surface Glycoprotein CD4 Product Picture
Figure 2. Global T Cell Surface Glycoprotein CD4 Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global T Cell Surface Glycoprotein CD4 Market Share by Type in 2024 & 2034
Figure 4. Forigerimod Acetate Product Picture
Figure 5. HIV Vaccine 2 Product Picture
Figure 6. Ibalizumab Product Picture
Figure 7. Others Product Picture
Figure 8. Global T Cell Surface Glycoprotein CD4 Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global T Cell Surface Glycoprotein CD4 Market Share by Application in 2024 & 2034
Figure 10. HIV
Figure 11. AIDS
Figure 12. GVHD
Figure 13. SARS
Figure 14. Others
Figure 15. T Cell Surface Glycoprotein CD4 Report Years Considered
Figure 16. Global T Cell Surface Glycoprotein CD4 Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global T Cell Surface Glycoprotein CD4 Revenue 2018-2034 (US$ Million)
Figure 18. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 19. Global T Cell Surface Glycoprotein CD4 Sales Quantity 2018-2034 (K Pcs)
Figure 20. Global T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Region (2018-2023)
Figure 21. Global T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America T Cell Surface Glycoprotein CD4 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 23. North America T Cell Surface Glycoprotein CD4 Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe T Cell Surface Glycoprotein CD4 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 25. Europe T Cell Surface Glycoprotein CD4 Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China T Cell Surface Glycoprotein CD4 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. China T Cell Surface Glycoprotein CD4 Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC T Cell Surface Glycoprotein CD4 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 29. APAC T Cell Surface Glycoprotein CD4 Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 31. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by T Cell Surface Glycoprotein CD4 Sales Quantity in 2024
Figure 33. The Top 10 and Top 5 Players Market Share by T Cell Surface Glycoprotein CD4 Revenue in 2024
Figure 34. T Cell Surface Glycoprotein CD4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 35. Global T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2018-2034)
Figure 37. Global T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2018-2034)
Figure 39. North America T Cell Surface Glycoprotein CD4 Revenue Market Share by Company in 2024
Figure 40. North America T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Company in 2024
Figure 41. North America T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2018-2034)
Figure 43. North America T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2018-2034)
Figure 45. North America T Cell Surface Glycoprotein CD4 Revenue Share by Country (2018-2034)
Figure 46. North America T Cell Surface Glycoprotein CD4 Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 48. Canada T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 49. Europe T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Company in 2024
Figure 50. Europe T Cell Surface Glycoprotein CD4 Revenue Market Share by Company in 2024
Figure 51. Europe T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2018-2034)
Figure 53. Europe T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2018-2034)
Figure 55. Europe T Cell Surface Glycoprotein CD4 Revenue Share by Country (2018-2034)
Figure 56. Europe T Cell Surface Glycoprotein CD4 Sales Quantity Share by Country (2018-2034)
Figure 57. Germany T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 58. France T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 60. Italy T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 61. Russia T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 62. China T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Company in 2024
Figure 63. China T Cell Surface Glycoprotein CD4 Revenue Market Share by Company in 2024
Figure 64. China T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Type (2018-2034)
Figure 65. China T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2018-2034)
Figure 66. China T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Application (2018-2034)
Figure 67. China T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2018-2034)
Figure 68. APAC T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Company in 2024
Figure 69. APAC T Cell Surface Glycoprotein CD4 Revenue Market Share by Company in 2024
Figure 70. APAC T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2018-2034)
Figure 72. APAC T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2018-2034)
Figure 74. APAC T Cell Surface Glycoprotein CD4 Revenue Share by Region (2018-2034)
Figure 75. APAC T Cell Surface Glycoprotein CD4 Sales Quantity Share by Region (2018-2034)
Figure 76. Japan T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 80. India T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America T Cell Surface Glycoprotein CD4 Revenue Share by Country (2018-2034)
Figure 89. Brazil T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 92. Israel T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries T Cell Surface Glycoprotein CD4 Revenue (2018-2034) & (US$ Million)
Figure 94. T Cell Surface Glycoprotein CD4 Value Chain
Figure 95. T Cell Surface Glycoprotein CD4 Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed